Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Group (NASDAQ:SBC) was covered in a Flash Report dated April 22, 2026, which reiterated a Buy-Extended rating and maintained a 12-month price target of $9.00 versus an April 21, 2026 share price of $3.65.

Rhea-AI Summary

SBC Medical Group (NASDAQ:SBC) was covered in a Flash Report dated April 22, 2026, which reiterated a Buy-Extended rating and maintained a 12-month price target of $9.00 versus an April 21, 2026 share price of $3.65.

The report attributes recent volatility to a secondary share issuance that reduced the founder's stake by ~3% without diluting shareholders, notes a potential public float increase to ~20%, cites a strong net cash position, and highlights management's target to return to revenue growth in 2026 alongside international M&A and AI-driven initiatives.

Positive

• 12-month price target of $9.00 reaffirmed
• Founder/CEO retains a significant majority stake
• Public float potentially increasing to ~20%, improving liquidity
• Company has a strong net cash position

Negative

• Secondary share issuance reduced founder stake by ~3%
• Shares declined after the offering due to discounted pricing
• Pricing-related revenue pressure occurred in 2025

Key Figures

Price target: $9.00 Recent share price: $3.65 Founder stake change: 3% reduction +3 more

Price target

$9.00

12-month target reiterated in Flash Report

Recent share price

$3.65

Company share price as of April 21, 2026

Founder stake change

3% reduction

Ownership reduction from recent secondary share issuance

Public float increase

Up to 20%

Potential increase in float from secondary transaction

Revenue pressure year

2025

Pricing-related revenue pressure referenced for 2025

Growth recovery target

2026

Management target for return to revenue growth

Historical Context

5 past events · Latest: Apr 21

5 events

1. Apr 21

   Secondary offering close

   24h Move

   -5.8%

   Closing of 3.1M-share secondary public offering at $3.25 price.

2. Apr 19

   Secondary offering pricing

   24h Move

   -17.1%

   Pricing of 3.1M-share secondary at $3.25 with underwriter option.

3. Apr 06

   Research rating update

   24h Move

   -1.3%

   Buy-Extended rating reiterated with $9.00 target after Q4:25 update.

4. Mar 27

   Earnings release

   24h Move

   +4.2%

   Q4 and FY25 results with revenue declines but EPS and net income growth.

5. Mar 24

   Strategy launch

   24h Move

   -1.0%

   Launch of “SBC Wellness 2.0” longevity platform leveraging 283 clinics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

secondary share issuance, public float, Russell Index, M&A, +2 more

6 terms

secondary share issuance financial

"SBC recently completed a secondary share issuance reflecting approximately a 3%..."

A secondary share issuance is when a company offers additional shares to the public after its initial listing, or when existing shareholders sell large blocks of stock through a formal market offering. Think of a pie that is cut into more slices: each existing owner's piece becomes smaller, which can lower the share price, but the company may raise cash for growth or debt, and selling shareholders can convert holdings to cash. Investors care because it changes ownership stakes, share supply, and often the near‑term valuation.

public float financial

"The increase in public float-potentially up to 20%-is expected to enhance..."

Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.

Russell Index financial

"could improve SBC's eligibility for inclusion in the Russell Index."

A Russell index is a market benchmark that groups stocks by size and other traits to track how that slice of the market is performing — for example small companies or large companies. Investors use it like a yardstick or thermometer to compare a fund’s returns, build index funds and ETFs, or gauge market trends; when the index moves, it signals how the particular segment of the market is doing.

M&A financial

"SBC is pursuing international M&A opportunities and new initiatives..."

M&A, short for mergers and acquisitions, involves one company combining with or purchasing another company to grow, streamline operations, or gain competitive advantages. For investors, M&A activity can signal potential for increased value, new opportunities, or changes in market dynamics, making it an important factor to watch in the business landscape.

View in glossary

AI-driven technical

"new initiatives in AI-driven operations and longevity-focused services."

AI-driven describes products, services, processes or decisions that rely on artificial intelligence—software that detects patterns in data and makes predictions or choices without step-by-step human direction. For investors it signals potential for faster growth, lower operating costs or new revenue, but also new risks (model errors, data problems, regulatory limits); think of it like a smart thermostat that can save energy and money but can also misbehave if fed bad information.

net cash position financial

"supported by a strong net cash position."

The net cash position is the amount of cash and easily sold assets a company has after subtracting its outstanding debt, essentially “money in the wallet” minus what it owes. Investors care because it shows how easily a company can cover bills, invest in growth, buy back shares, or weather a downturn — stronger net cash usually means lower financial risk and more strategic flexibility, much like a household with savings and little debt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026.

The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.

Key Highlights from the Flash Report:

• Secondary Share Transaction Misinterpreted by Market: SBC recently completed a secondary share issuance reflecting approximately a 3% reduction in the founder's ownership stake. Importantly, the transaction did not result in shareholder dilution, though shares declined following the offering due to the discounted pricing.

• Founder Alignment Remains Strong: Despite the transaction, the founder/CEO continues to hold a significant majority stake in the Company, reinforcing long-term alignment with shareholders.

• Improved Share Liquidity: The increase in public float-potentially up to 20%-is expected to enhance trading liquidity and may support broader institutional participation.

• Potential Index Inclusion Catalyst: Increased float-adjusted market capitalization could improve SBC's eligibility for inclusion in the Russell Index.

• Growth Recovery Expected in 2026: Following pricing-related revenue pressure in 2025, management continues to target a return to revenue growth during 2026.

• Strategic Expansion Initiatives: SBC is pursuing international M&A opportunities and new initiatives in AI-driven operations and longevity-focused services.

• Attractive Valuation: The recent share price pullback has created a disconnect between valuation and fundamentals, supported by a strong net cash position.

For a copy of the full Flash Report, please visit:
https://emerginggrowth.com/wp-content/uploads/2026/04/SBC_Flash-Report_4.22.26.pdf

Or

https://www.EmergingGrowth.com/profile/sbc/ (on the right side of the page as you scroll down)

About SBC Medical Group
SBC Medical Group Holdings, Inc. provides management services to cosmetic treatment centers through a franchise model, operating across Japan, Southeast Asia, and the United States.

About Emerging Growth Research
Emerging Growth Research is an independent equity research firm providing institutional-quality analysis on emerging growth companies.

Contact:
Emerging Growth Research
Research@EmergingGrowth.com
www.EmergingGrowth.com

Forward-Looking Statements
This press release contains forward-looking statements concerning business operations, financial performance, and future expectations of SBC Medical Group Holdings, Inc. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

SOURCE: SBC Medical Group Holdings Incorporated

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What price target did Emerging Growth Research set for SBC (NASDAQ:SBC) on April 22, 2026?

They reiterated a Buy-Extended rating and a 12-month price target of $9.00 on April 22, 2026. According to Emerging Growth Research, that target is cited versus SBC's April 21, 2026 share price of $3.65 and suggests significant upside from the current level.

Why did SBC (NASDAQ:SBC) shares fall after the recent secondary offering?

A secondary share offering priced at a discount triggered the share decline following the transaction. According to Emerging Growth Research, the offering reduced the founder's ownership by about 3% but did not dilute existing shareholders; discounted pricing is credited with the immediate share pressure.

Could SBC (NASDAQ:SBC) be added to the Russell indexes after the float change?

Increased public float could improve SBC's eligibility for Russell index inclusion, but inclusion is not guaranteed. According to Emerging Growth Research, a float-adjusted market-cap increase and a potential float up to ~20% are cited as possible catalysts for index consideration.

What does the Flash Report say about SBC's revenue outlook for 2026?

Management targets a return to revenue growth in 2026 after pricing-related revenue pressure in 2025. According to Emerging Growth Research, strategic international M&A and AI-driven operations are highlighted as initiatives intended to support the planned recovery, subject to execution.